Table 1.
Clinicopathological parameters | N = 83 | circRHOBTB3 expression | P value | |
---|---|---|---|---|
Low expression (n = 42) | High expression (n = 41) | |||
Gender | ||||
Male | 52 | 25 | 27 | |
Female | 31 | 17 | 14 | 0.551 |
Age | ||||
< 60 | 27 | 10 | 17 | |
≥ 60 | 56 | 32 | 24 | 0.086 |
Tumor location | ||||
Colon | 42 | 22 | 20 | |
Rectum | 41 | 20 | 21 | 0.743 |
Differentiation | ||||
Well and Moderate | 59 | 31 | 28 | |
Poor | 17 | 7 | 10 | 0.833 |
Clinical stage | ||||
I + II | 39 | 14 | 25 | |
III + IV | 44 | 28 | 16 | 0.012 |
T stage | ||||
T1-2 | 16 | 4 | 12 | |
T3-4 | 67 | 38 | 29 | 0.023 |
Lymph node metastasis | ||||
Absent | 43 | 15 | 28 | |
Present | 40 | 27 | 13 | 0.003 |
Distant metastasis | ||||
Absent | 70 | 33 | 37 | |
Present | 13 | 9 | 4 | 0.144 |
Nerve Invasion | ||||
Absent | 72 | 33 | 39 | |
Present | 10 | 9 | 1 | 0.009 |
Tumor size | ||||
≤ 5 cm | 65 | 29 | 36 | |
> 5 cm | 18 | 13 | 5 | 0.038 |
CEA level | ||||
< 5 µg/mL | 49 | 26 | 23 | |
≥ 5 µg/mL | 34 | 16 | 18 | 0.591 |
Chronic diarrhea or constipation | ||||
Absent | 52 | 25 | 27 | |
Present | 31 | 17 | 14 | 0.551 |
CEA: carcinoembryonic antigen; P values were calculated using chi-square tests.